Predictor | OR (95% CI) | p Value |
---|---|---|
All patients (n=546) | ||
Charlson comorbidity index | 1.15 (1.06 to 1.25) | 0.001 |
SF-12 physical score | 0.98 (0.96 to 1.00) | 0.020 |
Mild cognitive impairment | 1.53 (1.02 to 2.30) | 0.040 |
Men (n=402) | ||
Charlson comorbidity index | 1.14 (1.04 to 1.25) | 0.004 |
SF-12 physical score | 0.98 (0.96 to 1.00) | 0.030 |
Potential depression* | 1.95 (1.06 to 3.58) | 0.030 |
Women (n=162) | ||
Age | 1.06 (1.02 to 1.12) | 0.008 |
Mild cognitive impairment | 2.38 (1.09 to 5.18) | 0.030 |
Study-site (hospital-B) | 2.32 (1.09 to 4.93) | 0.030 |
*Positive PHQ-2 plus CES-D ≥16.
Bold value was statistically significant at <0.05.
SF-12, 12-item short-form score.